Cite
HARVARD Citation
Behrens, F. et al. (n.d.). FRI0117 Tocilizumab use directly after sdmard failure shows higher response rates and a longer treatment duration. Annals of the rheumatic diseases. p. 603. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Behrens, F. et al. (n.d.). FRI0117 Tocilizumab use directly after sdmard failure shows higher response rates and a longer treatment duration. Annals of the rheumatic diseases. p. 603. [Online].